期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
A genetic variant in pseudogene E2F3P1 contributes to prognosis of hepatocellular carcinoma 被引量:1
1
作者 Yun Pan Chongqi Sun +9 位作者 Mingde Huang Yao Liu Fuzhen Qi Li Liu Juan Wen Jibin Liu Kaipeng Xie Hongxia Ma Zhibin Hu Hongbing Shen 《The Journal of Biomedical Research》 CAS 2014年第3期194-200,共7页
Certain pseudogenes may regulate their protein-coding cousins by competing for miRNAs and play an active biological role in cancer. However, few studies have focused on the association of genetic variations in pseudog... Certain pseudogenes may regulate their protein-coding cousins by competing for miRNAs and play an active biological role in cancer. However, few studies have focused on the association of genetic variations in pseudogenes with cancer prognosis. We selected six potentially functional single nucleotide polymorphisms (SNPs) in cancerrelated pseudogenes, and performed a case-only study to assess the association between those SNPs and the prognosis of hepatocellular carcinoma (HCC) in 331 HBV-positive HCC patients without surgical treatment. Log-rank test and Cox proportional hazard models were used for survival analysis. We found that the A allele of rs9909601 in E2F3P1 was significantly associated with a better prognosis compared with the G allele [adjusted hazard ratio (HR) = 0.69, 95% confidence interval (CI) = 0.56-0.86, P = 0.001]. Additionally, this protective effect was more predominant for patients without chemotherapy and transcatheter hepatic arterial chemoembolization (TACE) treatment. Interestingly, we also detected a statistically significant multiplicative interaction between genotypes of rs9909601 and chemotherapy or TACE status on HCC survival (P for multiplicative interaction 〈 0.001). These findings indicate that rs9909601 in the pseudogene E2F3P1 may be a genetic marker for HCC prognosis in Chinese. 展开更多
关键词 PSEUDOGENE E2F3P1 SNP hepatocellular carcinoma (HCC) PROGNOSIS
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部